J. Reiland et al., PERVANADATE ACTIVATION OF INTRACELLULAR KINASES LEADS TO TYROSINE PHOSPHORYLATION AND SHEDDING OF SYNDECAN-1, Biochemical journal, 319, 1996, pp. 39-47
Syndecan-1 is a transmembrane haparan sulphate proteoglycan that binds
extracellular matrices and growth factors, making it a candidate to a
ct between these regulatory molecules and intracellular signalling pat
hways. It has a highly conserved transmembrane/cytoplasmic domain that
contains four conserved tyrosines. One of these is in a consensus seq
uence for tyrosine kinase phosphorylation. As an initial step to inves
tigating whether or not phosphorylation of these tyrosines is part of
a signal-transduction pathway, we have monitored the tyrosine phosphor
ylation of syndecan-1 by cytoplasmic tyrosine kinases in intact cells.
Tyrosine phosphorylation of syndecan-1 is observed when NMuMG cells a
re treated with sodium orthovanadate or pervanadate, which have been s
hown to activate intracellular tyrosine kinases, Initial studies with
sodium orthovanadate demonstrate a slow accumulation of phosphotyrosin
e on syndecan-1 over the course of several hours. Pervanadate, a more
effective inhibitor of phosphatases, allows detection of phosphotyrosi
ne on syndecan-1 within 5 min, with peak phosphorylation seen by 15 mi
n. Concurrently, in a second process activated by pervanadate, syndeca
n-1 ectodomain is cleaved and released into the culture medium. Two ph
osphorylated fragments of syndecan-1 of apparent sizes 6 and 8 kDa rem
ain with the cell after shedding of the ectodomain. The 8 kDa size cla
ss appears to be a highly phosphorylated form of the 6 kDa product, as
it disappears if samples are dephosphorylated. These fragments contai
n the C-terminus of syndecan-1 and also retain at least a portion of t
he transmembrane domain, suggesting that they are produced by a cell s
urface cleavage event. Thus pervanadate treatment of cells results in
two effects of syndecan-1: (i) phosphorylation of one or more of its t
yrosines via the action of a cytoplasmic kinase(s) and (ii) cleavage a
nd release of the ectodomain into the medium, producing a C-terminal f
ragment containing the transmembrane/cytoplasmic domain.